Major antepartum haemorrhage – coagulopathy

A woman at 38 weeks presents with a major placental abruption. She is actively bleeding and requires resuscitation. Which complication should be specifically anticipated because of the underlying diagnosis?

A woman at 36+5 weeks has a major placental abruption with continuing haemorrhage. Despite red-cell replacement, she remains actively bleeding. The uterus is tense and tender. Laboratory results are delayed, but consumptive coagulopathy is strongly suspected. Which is the most appropriate management while definitive coagulation results are awaited?

A woman at 37 weeks has a major placental abruption complicated by ongoing haemorrhage. Following red-cell and plasma replacement, bleeding continues from venepuncture sites. Her platelet count is 82 × 10⁹/L and fibrinogen is 0.8 g/L. Which abnormality should prompt particularly urgent targeted replacement because it indicates severe depletion of a coagulation substrate during obstetric haemorrhage?

A woman with placental abruption has ongoing massive haemorrhage despite red-cell and plasma replacement. She is proceeding to emergency operative delivery. Her platelet count has fallen to 42 × 10⁹/L and diffuse microvascular bleeding is evident. Which blood component most directly addresses the demonstrated cellular haemostatic deficit?

A woman with massive placental abruption is receiving active transfusion. She continues to bleed diffusely. Results are: Hb 84 g/L, platelet count 76 × 10⁹/L, fibrinogen 0.7 g/L and markedly prolonged clotting times. She has already received red cells and fresh frozen plasma. Which additional component most specifically addresses the most striking residual haemostatic abnormality?

A woman at 37+6 weeks has a severe placental abruption with continuing haemorrhage. After initial resuscitation she remains tachycardic but her blood pressure has improved. Results show Hb 96 g/L, platelets 58 × 10⁹/L, fibrinogen 0.9 g/L and prolonged PT and APTT. Which management concept is most appropriate?

A woman with severe placental abruption is undergoing resuscitation. Her first laboratory results show Hb 109 g/L, platelets 168 × 10⁹/L and normal coagulation studies. Forty-five minutes later, despite continuing haemorrhage, a clinician argues that significant consumptive coagulopathy is unlikely because the original results were normal. Which response is most appropriate?

A woman with major placental abruption has continuing haemorrhage during resuscitation. Serial results are: Hb: 121 → 94 g/L; Platelets: 176 → 68 × 10⁹/L; Fibrinogen: 3.6 → 1.0 g/L; PT and APTT: initially normal → prolonged. Which interpretation best integrates these changes?

A woman with severe placental abruption has received red cells and fresh frozen plasma during continuing massive haemorrhage. Repeat tests show Hb 88 g/L, platelets 104 × 10⁹/L, fibrinogen 0.6 g/L and improving PT/APTT. Diffuse bleeding persists. Which result most specifically identifies an inadequately corrected haemostatic deficit requiring targeted component replacement?

Select the single most appropriate interpretation and response.

Select the single most appropriate interpretation and management priority.

Select the single most appropriate approach to haemostatic reassessment.